YARW Yarrow Bioscience, Inc.: institutional ownership and insider trading
45 funds reported holding $8.96M of Yarrow Bioscience, Inc. in their latest 13F filings; in Q2 2026 funds net bought $199K, with 6 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding YARW
- Ken Griffin (Citadel Advisors): $305K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $286K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $15.2K, 0.0% of the portfolio
Largest institutional holders of YARW
- ADAR1 Capital Management, LLC — $1.92M
- Nantahala Capital Management, LLC — $1.30M
- Lynx1 Capital Management LP — $1.06M
- Shay Capital LLC — $948K
- Deeter Investments LLP — $651K
- BRAIDWELL LP — $596K
- KVP Capital Advisors, LP — $326K
- CITADEL ADVISORS LLC — $305K
- TWO SIGMA INVESTMENTS, LP — $286K
- ACADIAN ASSET MANAGEMENT LLC — $248K
Recent YARW insider trades
- Jan 15, 2025: Lepore Patrick G bought 15,000 shares ($43.8K)
5%+ owners
- Nantahala Capital Management, LLC: 6.0% (Schedule 13G, filed May 15, 2026)
- Zhang Xiaofan: 0.0% (Schedule 13G/A, filed Jul 17, 2026)